Margin Probe Is Game-Changer For Breast Cancer
Virginia Hospital Center in Arlington is one of only five hospitals in the country using the FDA approved Margin Probe intra-operative device. Margin Probe allows surgeons to immediately assess whether cancer is still present at the edges of a just-removed tumor while the patient is still in the operating room.
Dr. Stephanie Akbari, Medical Director of the Reinsch Pierce Family Center for Breast Health at VHC, says “One of the biggest frustrations for patients having lumpectomies is we don’t know while they’re asleep that their lumpectomy specimen is sufficient.”
Dr. Stephanie Akbari believes Margin Probe is a game changer for treating early stage breast cancer.